{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:37:34Z","timestamp":1790775454225,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jaip.2022.07.018","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T19:35:18Z","timestamp":1661024118000},"page":"3124-3130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Diphenhydramine: Time to Move on?"],"prefix":"10.1016","volume":"10","author":[{"given":"Anna R.","family":"Wolfson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Waserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon L.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.07.018_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2222.1999.00004.x-i1","article-title":"Histamine and the antiallergic antihistamines: a history of their discoveries","volume":"29","author":"Emanuel","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib2","series-title":"CSACI statement, The Medical Post OTC Survey","year":"2019"},{"key":"10.1016\/j.jaip.2022.07.018_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","article-title":"Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper","volume":"65","author":"Church","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2125.2008.03143.x","article-title":"Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin","volume":"65","author":"Tashiro","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2022.07.018_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"63","author":"Brown","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jaip.2022.07.018_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Histamine and H1-antihistamines: celebrating a century of progress","volume":"128","author":"Simons","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1081-1206(10)62855-4","article-title":"H1-receptor antagonists: safety issues","volume":"83","author":"Estelle","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1185\/030079906X112660","article-title":"Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects","volume":"22","author":"Boyle","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2022.07.018_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","article-title":"Histamine in the regulation of wakefulness","volume":"15","author":"Thakkar","year":"2011","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jaip.2022.07.018_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0024-3205(93)90592-Q","article-title":"Involvement of histamine in the control of the waking state","volume":"53","author":"Monti","year":"1993","journal-title":"Life Sci"},{"key":"10.1016\/j.jaip.2022.07.018_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-132-5-200003070-00004","article-title":"Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator","volume":"132","author":"Weiler","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/j.1552-4604.1990.tb01871.x","article-title":"Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children","volume":"30","author":"Simons","year":"1990","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jaip.2022.07.018_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13223-019-0375-9","article-title":"CSACI position statement: newer generation H(1)-antihistamines are safer than first-generation H(1)-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria","volume":"15","author":"Fein","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2007.03.034","article-title":"Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study","volume":"120","author":"Walker","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib15","first-page":"514","article-title":"First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005","volume":"78","author":"Sen","year":"2007","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2125.2012.04279.x","article-title":"A\u00a0European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project","volume":"74","author":"Ravera","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2022.07.018_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.forsciint.2006.01.019","article-title":"Poisonings with diphenhydramine--a survey of 68 clinical and 55 death cases","volume":"161","author":"Pragst","year":"2006","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jaip.2022.07.018_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.paf.0000188093.45675.ee","article-title":"Fatality from diphenhydramine monointoxication: a case report and review of the infant, pediatric, and adult literature","volume":"27","author":"Nine","year":"2006","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.jaip.2022.07.018_bib19","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1056\/NEJMp0707400","article-title":"Over the counter but no longer under the radar--pediatric cough and cold medications","volume":"357","author":"Sharfstein","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1520\/JFS2002121","article-title":"Fatal diphenhydramine intoxication in infants","volume":"48","author":"Baker","year":"2003","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.jaip.2022.07.018_bib21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0002-9149(97)00634-6","article-title":"Electrocardiographic findings in patients with diphenhydramine overdose","volume":"80","author":"Zareba","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaip.2022.07.018_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.pa.36.040196.001313","article-title":"Cardiac actions of antihistamines","volume":"36","author":"Woosley","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jaip.2022.07.018_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5114\/pdia.2014.43191","article-title":"Cardiovascular safety of antihistamines","volume":"31","author":"Olasi\u0144ska-Wi\u015bniewska","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jaip.2022.07.018_bib24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/tx800020c","article-title":"Cardiotoxic effects of antihistamines: from basics to clinics (...and back)","volume":"21","author":"Soldovieri","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jaip.2022.07.018_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1081-1206(10)63435-7","article-title":"Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis","volume":"76","author":"Vuurman","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib26","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1001\/archinte.161.17.2091","article-title":"Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients","volume":"161","author":"Agostini","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib28","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.jaci.2009.12.981","volume":"125","author":"Simons","year":"2010","journal-title":"Anaphylaxis. J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib29","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1017\/cem.2020.458","article-title":"Management of pediatric allergic reaction: practice patterns of Canadian pediatric emergency physicians","volume":"22","author":"Prendergast","year":"2020","journal-title":"CJEM"},{"key":"10.1016\/j.jaip.2022.07.018_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpeds.2021.10.011","article-title":"Separating fact from fiction in the diagnosis and management of food allergy","volume":"241","author":"Abrams","year":"2022","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2022.07.018_bib31","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib32","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib33","article-title":"Anti-histamines for prolonged non-specific cough in children","volume":"2008","author":"Chang","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2022.07.018_bib34","series-title":"Antihistamines for the common cold","author":"Sutter","year":"2003"},{"key":"10.1016\/j.jaip.2022.07.018_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14785\/lymphosign-2018-0016","article-title":"Histamine, histamine receptors, and anti-histamines in the context of allergic responses","volume":"6","author":"Mandola","year":"2019","journal-title":"LymphoSign J"},{"key":"10.1016\/j.jaip.2022.07.018_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10611860108997930","article-title":"Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines","volume":"9","author":"Chishty","year":"2001","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.jaip.2022.07.018_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(96)00355-9","article-title":"Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole","volume":"385","author":"Suessbrich","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaip.2022.07.018_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/ijpd.ijpd_124_21","article-title":"Antihistamines in children: a dermatological perspective","volume":"23","author":"Kohli","year":"2022","journal-title":"Ind J Paediatr Dermatol"},{"key":"10.1016\/j.jaip.2022.07.018_bib39","first-page":"1","article-title":"Use of second generation H1 antihistamines in special situations","volume":"23","author":"Davila","year":"2013","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib40","first-page":"163","article-title":"High-dose loratadine exposure in a six-year-old child","volume":"43","author":"Cobb","year":"2001","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.jaip.2022.07.018_bib41","first-page":"525","article-title":"Retrospective evaluation of cetirizine (zyrtec) ingestion","volume":"40","author":"Spiller","year":"2002","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.jaip.2022.07.018_bib42","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Advances in H1-antihistamines","volume":"351","author":"Simons","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1067\/mai.2003.1408","article-title":"Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis","volume":"111","author":"Bender","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1081-1206(10)61950-3","article-title":"Increased risk of serious injury following an initial prescription for diphenhydramine","volume":"89","author":"Finkle","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib45","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/bmj.320.7243.1184","article-title":"Sedation with \u201cnon-sedating antihistamines: four prescription-event monitoring studies in general practice","volume":"320","author":"Mann","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2022.07.018_bib46","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/0091270004267590","article-title":"Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography","volume":"44","author":"Tashiro","year":"2004","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jaip.2022.07.018_bib47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1398-9995.2009.02217.x","article-title":"Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study","volume":"65","author":"Zuberbier","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib48","first-page":"433","article-title":"Pathobiology of second-generation antihistamines related to sleep in urticaria patients","volume":"11","author":"Mann","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jaip.2022.07.018_bib49","first-page":"2","article-title":"Antihistamines and aircrew: usefulness of fexofenadine","volume":"71","author":"Nicholson","year":"2000","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-4362.2001.00186.x","article-title":"Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study","volume":"40","author":"Ring","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2022.07.018_bib51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)62086-8","article-title":"Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion","volume":"89","author":"Berger","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mai.2003.168","article-title":"Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis","volume":"111","author":"Simons","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib53","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mjd.2003.143","article-title":"Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial","volume":"48","author":"Monroe","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2022.07.018_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1398-9995.2008.01813.x","article-title":"Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients","volume":"64","author":"Bachert","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib55","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S1081-1206(10)61325-7","article-title":"Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study","volume":"94","author":"Kaplan","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib56","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1081-1206(10)60914-3","article-title":"Desloratadine therapy for symptoms associated with perennial allergic rhinitis","volume":"96","author":"Kim","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.2005.07049.x","article-title":"Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study","volume":"154","author":"Nettis","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.07.018_bib58","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2006.07533.x","article-title":"Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study","volume":"155","author":"Nettis","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.07.018_bib59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000077357","article-title":"Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study","volume":"133","author":"Ratner","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib60","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/cea.13500","article-title":"Cardiac safety of second-generation H1-antihistamines when updosed in chronic spontaneous urticaria","volume":"49","author":"Cataldi","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-3038.1993.tb00339.x","article-title":"A\u00a0placebo-controlled trial of cetirizine in seasonal allergic rhino-conjunctivitis in children aged 6 to 12 years","volume":"4","author":"Masi","year":"1993","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib62","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0091-6749(89)90303-5","article-title":"Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis","volume":"84","author":"Del Carpio","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib63","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.annemergmed.2020.05.025","article-title":"Intravenous cetirizine versus intravenous diphenhydramine for the treatment of acute urticaria: a phase III randomized controlled noninferiority trial","volume":"76","author":"Abella","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00002018-200124020-00003","article-title":"Safety of antihistamines in children","volume":"24","author":"Ten Eick","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2022.07.018_bib65","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00431-019-03559-6","article-title":"Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria","volume":"179","author":"Rodriguez","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaip.2022.07.018_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176091","article-title":"Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children","volume":"12","author":"Santamaria","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2022.07.018_bib67","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0091-6749(90)90091-H","article-title":"A\u00a0double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects","volume":"86","author":"Simons","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/106002809603001001","article-title":"Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria","volume":"30","author":"Breneman","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2022.07.018_bib69","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jaci.2011.08.026","article-title":"Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactions","volume":"128","author":"Park","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib70","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1081-1206(10)63557-0","article-title":"Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis","volume":"96","author":"Raphael","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib71","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archfami.9.8.748","article-title":"SOAP: solutions to often asked problems. Choice of antihistamines for urticaria","volume":"9","author":"Alper","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.jaip.2022.07.018_bib72","first-page":"433","article-title":"Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria","volume":"67","author":"Sussman","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib73","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0091-6749(05)80244-1","article-title":"Perennial allergic rhinitis: clinical efficacy of a new antihistamine","volume":"86","author":"Berman","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib74","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib75","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2500\/aap.2009.30.3226","article-title":"The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines","volume":"30","author":"Gillman","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2022.07.018_bib76","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1034\/j.1398-9995.1999.00032.x","article-title":"A\u00a0double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects","volume":"54","author":"Grant","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.07.018_bib77","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib78","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4065\/80.9.1170","article-title":"Evaluation of the optimal oral antihistamine for patients with allergic rhinitis","volume":"80","author":"Meltzer","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2022.07.018_bib79","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0091-6749(99)70070-9","article-title":"Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis","volume":"104","author":"Howarth","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.07.018_bib80","first-page":"108","article-title":"International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis","volume":"8","author":"Wise","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.07.018_bib81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1358\/dot.2003.39.6.799450","article-title":"Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis","volume":"39","author":"Izquierdo","year":"2003","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.jaip.2022.07.018_bib82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1398-9995.2001.00101.x","article-title":"The pharmacologic profile of desloratadine: a review","volume":"56","author":"Henz","year":"2001","journal-title":"Allergy"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822007462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822007462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:16Z","timestamp":1761975376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822007462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213219822007462"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.07.018","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diphenhydramine: Time to Move on?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}